256 related articles for article (PubMed ID: 15238096)
1. Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease.
Wolff D; Anders V; Corio R; Horn T; Morison WL; Farmer E; Vogelsang GB
Photodermatol Photoimmunol Photomed; 2004 Aug; 20(4):184-90. PubMed ID: 15238096
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA).
Vogelsang GB; Wolff D; Altomonte V; Farmer E; Morison WL; Corio R; Horn T
Bone Marrow Transplant; 1996 Jun; 17(6):1061-7. PubMed ID: 8807115
[TBL] [Abstract][Full Text] [Related]
3. PUVA therapy for chronic cutaneous graft-vs-host disease.
Jampel RM; Farmer ER; Vogelsang GB; Wingard J; Santos GW; Morison WL
Arch Dermatol; 1991 Nov; 127(11):1673-8. PubMed ID: 1952971
[TBL] [Abstract][Full Text] [Related]
4. The effect of budesonide mouthwash on oral chronic graft versus host disease.
Sari I; Altuntas F; Kocyigit I; Sisman Y; Eser B; Unal A; Fen T; Ferahbas A; Ozturk A; Unal A; Cetin M
Am J Hematol; 2007 May; 82(5):349-56. PubMed ID: 17109390
[TBL] [Abstract][Full Text] [Related]
5. Oral graft vs. host disease in children--treatment with topical tacrolimus ointment.
Albert MH; Becker B; Schuster FR; Klein B; Binder V; Adam K; Nienhoff C; Führer M; Borkhardt A
Pediatr Transplant; 2007 May; 11(3):306-11. PubMed ID: 17430488
[TBL] [Abstract][Full Text] [Related]
6. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
[TBL] [Abstract][Full Text] [Related]
7. Topical cyclosporin A for treatment of oral chronic graft-versus-host disease.
Epstein JB; Reece DE
Bone Marrow Transplant; 1994 Jan; 13(1):81-6. PubMed ID: 8019458
[TBL] [Abstract][Full Text] [Related]
8. PUVA therapy for drug-resistant graft-versus-host disease.
Atkinson K; Weller P; Ryman W; Biggs J
Bone Marrow Transplant; 1986 Dec; 1(2):227-36. PubMed ID: 3502781
[TBL] [Abstract][Full Text] [Related]
9. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
Elad S; Levitt M; M Y S
Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
[TBL] [Abstract][Full Text] [Related]
10. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses.
Engin B; Oguz O
Int J Dermatol; 2005 Apr; 44(4):337-9. PubMed ID: 15811091
[TBL] [Abstract][Full Text] [Related]
12. Chronic graft versus host disease of oral mucosa: review of available therapies.
Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study.
Wiesmann A; Weller A; Lischka G; Klingebiel T; Kanz L; Einsele H
Bone Marrow Transplant; 1999 Jan; 23(2):151-5. PubMed ID: 10197800
[TBL] [Abstract][Full Text] [Related]
14. Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD.
Andree H; Hilgendorf I; Leithaeuser M; Junghanss C; Holzhueter S; Loddenkemper C; Steiner B; Freund M; Wolff D
Bone Marrow Transplant; 2008 Oct; 42(8):541-6. PubMed ID: 18641680
[TBL] [Abstract][Full Text] [Related]
15. PUVA-bath photochemotherapy and isotretinoin in sclerodermatous graft-versus-host disease.
Ghoreschi K; Thomas P; Penovici M; Ullmann J; Sander CA; Ledderose G; Plewig G; Kolb HJ; Röcken M
Eur J Dermatol; 2008; 18(6):667-70. PubMed ID: 18955201
[TBL] [Abstract][Full Text] [Related]
16. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
[TBL] [Abstract][Full Text] [Related]
17. Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease.
Epstein JB; Nantel S; Sheoltch SM
Bone Marrow Transplant; 2000 Mar; 25(6):683-7. PubMed ID: 10734307
[TBL] [Abstract][Full Text] [Related]
18. Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD.
Mawardi H; Stevenson K; Gokani B; Soiffer R; Treister N
Bone Marrow Transplant; 2010 Jun; 45(6):1062-7. PubMed ID: 19881552
[TBL] [Abstract][Full Text] [Related]
19. Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease.
Elad S; Or R; Resnick I; Shapira MY
Transpl Int; 2003 Sep; 16(9):665-70. PubMed ID: 12768230
[TBL] [Abstract][Full Text] [Related]
20. The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata.
Behrens-Williams SC; Leiter U; Schiener R; Weidmann M; Peter RU; Kerscher M
J Am Acad Dermatol; 2001 Feb; 44(2):248-52. PubMed ID: 11174382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
